期刊文献+

组蛋白乙酰化与癌症 被引量:10

Histone Acetylation and Cancer
暂未订购
导出
摘要 由于组蛋白被修饰所引起的染色质结构的改变 ,在真核生物基因表达调控中发挥着重要的作用 ,这些修饰主要包括甲基化、乙酰化、磷酸化和泛素化等 ,其中组蛋白乙酰化尤为重要 .组蛋白乙酰转移酶 (HAT)和组蛋白去乙酰化酶 (HDAC)参与决定组蛋白乙酰化状态 .HAT通常作为多亚基辅激活物复合体的一部分 ,催化组蛋白乙酰化 ,导致染色质结构的松散、激活转录 ;而HDAC是多亚基辅抑制物复合体的一部分 ,使组蛋白去乙酰化 ,导致染色质集缩 ,并抑制基因的转录 .编码这些酶的基因染色体易位易于导致急性白血病的发生 .另一方面 ,已经确定了一些乙酰化修饰酶的基因在染色体上的位置 ,它们尤其倾向定位于染色体的断裂处 .综述了HAT和HDAC参与的组蛋白乙酰化与癌症发生之间关系的最新进展 ,以期进一步阐明组蛋白乙酰化修饰酶的生物学功能以及它们在癌症发生过程中的作用 . Alterations in chromatin structure by histone post-translational modifications appear to play a central role in the regulation of gene transcription. Histone modifications consist of methylation, acetylation, phosphorylation and ubiquityination. Among them histone acetylation is of critical importance. The level of histone acetylation depends on the activity of two families of enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs). HATs, which is frequently part of multisubunit coactivator complexes, lead to the relaxation of chromatin structure and transcriptional activation, while HDACs tend to associate with multisubunit corepressor complexes, resulting in chromatin condensation and transcriptional repression of specific target genes. Chromosomal translocations are often associated with acute leukemias, and a significant number of translocations involve genes encoding HATs and HDACs. On the other hand, some histone acetylation modifying enzymes have been located within chromosomal regions that are particularly prone to chromosomal breaks. The recent achievements in studies aimed at elucidating the biological roles of histone acetylation modifying enzymes and their potential impacts on the molecular changes involved in the development of cancers are reviewed.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2003年第1期19-23,共5页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金 ( 39970 384) 国家重点基础研究发展规划(G19990 5 390 2 )资助项目 .~~
关键词 组蛋白乙酰化 组蛋白乙酰转移酶 组蛋白去乙酰化酶 癌症 肿瘤发生 histone acetylation histone acetyltransferases (HATs) histone deacetylases (HDACs) cancer
  • 相关文献

参考文献30

  • 1Roth S Y, Denu J M, Allis C D. Histone Acetyltransferases. Annu Rev Biochem, 2001, 70:81~120
  • 2Brown R, Strathdee G. Epigenomics and epigenetic therapy of cancer. Trends Mol Med Suppl, 2002, 8(4):S43~S48
  • 3Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev, 1999, 9(1):40~48
  • 4Fenrick R, Hiebert S W. Role of histone deacetylases in acute leukemia. J Cell Biochem, 1998, 30-31(Suppl):194~202
  • 5Brownell J E, Allis C D. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev, 1996, 6(2):176~184
  • 6Ruiz-Carrillo A, Aangh L J, Allfrey V G. Processing of newly synthesized histone molecules. Science, 1975, 190(4210):117~128
  • 7Sterner D E, Berger S L. Acetylation of histones and transcription-related factors. Microbiology and Molecular Biology Reviews, 2000,64(2):435~459
  • 8黄百渠,曾庆华,毕晓辉,王玉红,李玉新.组蛋白和核小体在基因转录中的作用[J].科学通报,2000,45(19):2033-2040. 被引量:7
  • 9Yang W M, Yao Y L, Sun J M, et al. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J Biol Chem, 1997, 272(44):28001~28007
  • 10Dangond F, Hafler D A, Tong J K, et al. Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells. Biochem Biophys Res Commun, 1998, 242(3):648~652

二级参考文献8

共引文献6

同被引文献71

  • 1尹子卉,吴仲闻,兰玉坤,廖晨钟,山松,李志良,宁志强,鲁先平,李志斌.新型抗肿瘤组蛋白去乙酰化酶抑制剂西达本胺的合成[J].中国新药杂志,2004,13(6):536-538. 被引量:8
  • 2刘元江.组蛋白去乙酰化酶抑制剂的抗肿瘤活性[J].国外医学(药学分册),2007,34(1):70-71. 被引量:1
  • 3Ji L,Fang B,Yen N,et al.Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Research . 1999
  • 4Roz L,Gramegna M,Ishii H,et al.Restoration of fragile histidine triad (GHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. Proceedings of the National Academy of Sciences of the United States of America . 2002
  • 5Marks P,Rifkind RA,Richon VM,et al.Histone deacetylases and cancer: causes and therapies. Nature Reviews Cancer . 2001
  • 6John Patrick Alao,Eric W-F.Lam,Simak Ali et al.HistoneDeacetylase Inhibitor Trichostatin A Represses Estrogen Re-ceptor-αDependent Transcription and Promotes ProteasomalDegradation of Cyclin D1 in Human Breast Carcinoma CellLines. Clinical Cancer Research . 2004
  • 7Burroughs A,Hochhauser D,Meyer T.Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. The Lancet Oncology . 2004
  • 8刘维民,闫凯麟,吴智群.TSA对人肝癌细胞SMMC-7721的抑制作用及其机制[J].现代肿瘤医学,2007,15(10):1373-1375. 被引量:8
  • 9Redig AJ,Mc Allister SS.Breast cancer as a systemic disease:a view of metastasis[J].J Intern Med,2013,274(2):113-126.
  • 10Anders CK,Deal AM,Miller CR,et al.The prognostic contribution of clinical breast cancer subtype,age,and race among patients with breast cancer brain metastases[J].Cancer,2011,117(8):1602-1611.

引证文献10

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部